Analysis-GSK, Pfizer RSV vaccine sales fall in US
GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...
In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...
You may have been too young to remember, but depending on your state’s school immunization requirements, you likely received ...
The RSV vaccine is unequivocally recommended for adults who are residents in skilled nursing and assisted living facilities.
In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...
GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...
While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
10h
The vaccine is recommended for use only in the run-up to RSV season. It's time for RSV, flu, and COVID shots, and the CDC has ...
Sanofi - Aventis Groupe said that the data featured at IDWeek from several national immunization programs will reinforce the proven ...
Kathryn Thomas has reflected on rushing her daughter to the hospital after she contracted RSV at just three weeks old.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback